Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results
Nov 26, 2008 04:31 PM
- /C O R R E C T I O N -- Rosetta Genomics Ltd/
Nov 06, 2008 10:40 AM
- Rosetta Genomics to Present at Rodman & Renshaw 10th Annual Healthcare Conference
Nov 05, 2008 08:31 AM
- Rosetta Genomics to Present at the American Association of Cancer Research (AACR) Centennial Conference
Nov 03, 2008 08:04 AM
- Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference
Oct 29, 2008 08:31 AM
- Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics
Oct 27, 2008 04:47 PM
- Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative
Oct 27, 2008 08:41 AM
- Rosetta Genomics to Present at the Upcoming EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in Cancer"
Oct 23, 2008 08:31 AM
- Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay
Oct 02, 2008 08:31 AM
- Rosetta Genomics is the Winner of the Medical-Biotech Category in This Year's Wall Street Journal Technology Innovation Awards
Sep 29, 2008 08:32 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
ROSG
|
Compare to S&P
|
| YTD |
-57.88 %
|
-30.99 %
|
| 4 Weeks |
-11.63 %
|
-4.48 %
|
| 12 Weeks |
-43.15 %
|
-21.19 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 6.06 %
|
|
EPS Growth in Last Year: -63.16 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
|
